Patient education materials related to age-related macular degeneration treatment are often written at inappropriate reading levels and lack accountability, according to a presentation at the American Society of Retina Specialists meeting.
“After a patient is diagnosed with AMD, it is likely that they turn to the internet to learn more about their disease,” Carolyn K. Pan, MD, of the Byers Eye Institute at Stanford University, said.
Online searches for new treatments tend to rise after FDA approval, so “it is imperative that patient education materials that currently populate